Create account

Coverage dated June 4, 2024 to June 5, 2024

FDA advisers: Target JN.1 strain in fall’s COVID vaccine

Headline from The Columbian

WASHINGTON — Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall — targeting a version of the ever-evolving coronavirus calle

The Columbian's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

6 articles, oldest first.

  1. Forbes

    FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall (opens Forbes)

    Published

    Forbes's feed description

    Drug manufactures Moderna, Pfizer and Novavax said they expect the new vaccines will be available this fall in time for flu season.

  2. Minneapolis Star Tribune

    FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines (opens Minneapolis Star Tribune)

    Published

    Minneapolis Star Tribune's feed description

    Government advisers Wednesday said it's time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving coronavirus called JN.1.

  3. The Columbian

    FDA advisers: Target JN.1 strain in fall’s COVID vaccine (opens The Columbian)

    Published

    The Columbian's feed description

    WASHINGTON — Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall — targeting a version of the ever-evolving coronavirus calle

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

FDA advisers: Target JN.1 strain in fall’s COVID vaccine | Since Then